Steve Kaye
Overview
Explore the profile of Steve Kaye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1270
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan M, Bradshaw D, Brown C, Haddow J, Patel P, Tosswill J, et al.
Open Forum Infect Dis
. 2023 May;
10(5):ofad108.
PMID: 37152187
Background: We report outcomes and novel characterization of a unique cohort of 42 individuals with persistently indeterminate human immunodeficiency virus (HIV) status, the majority of whom are HIV viral controllers....
2.
Kibirige C, Manak M, King D, Abel B, Hack H, Wooding D, et al.
Sci Rep
. 2022 Jul;
12(1):11792.
PMID: 35821052
No abstract available.
3.
Kibirige C, Manak M, King D, Abel B, Hack H, Wooding D, et al.
Sci Rep
. 2022 Feb;
12(1):1980.
PMID: 35105930
No abstract available.
4.
Kibirige C, Manak M, King D, Abel B, Hack H, Wooding D, et al.
Sci Rep
. 2022 Jan;
12(1):1550.
PMID: 35091568
An LTR-based quantitative PCR (qPCR) assay was modified and optimized for the quantification of total HIV-1 nucleic acids in plasma and PBMC. TaqMan qPCR primers and probes were designed against...
5.
Fidler S, Stohr W, Pace M, Dorrell L, Lever A, Pett S, et al.
Lancet
. 2020 Feb;
395(10227):888-898.
PMID: 32085823
Background: Antiretroviral therapy (ART) cannot cure HIV infection because of a persistent reservoir of latently infected cells. Approaches that force HIV transcription from these cells, making them susceptible to killing-termed...
6.
Ferretti F, Mackie N, Singh G, Fox J, Kaye S, McClure M, et al.
HIV Res Clin Pract
. 2020 Feb;
20(4-5):107-110.
PMID: 32000615
To understand the pathogenesis of low level viraemia (LLV) in HIV-infected patients on boosted protease inhibitors (PI/b), we enrolled 34 subjects with a median HIV-RNA 79 copies/mL and followed them...
7.
Skelton J, Ortega-Prieto A, Kaye S, Jimenez-Guardeno J, Turner J, Malim M, et al.
J Virol
. 2019 Mar;
93(11).
PMID: 30867315
Human immunodeficiency virus type 1 (HIV-1) infection is associated with aberrant immune activation; however, most model systems for HIV-1 have been used during established infection. Here, we utilize ultrasensitive HIV-1...
8.
Singh G, Kaye S, Abbott J, Boesecke C, Rockstroh J, McClure M, et al.
HIV Clin Trials
. 2018 Mar;
19(2):46-51.
PMID: 29493385
Background The epidemic of acute HCV infection among HIV-infected men who have sex with men (MSM) is ongoing. Transmission of drug-resistant variants (DRVs) after HCV treatment failure could pose a...
9.
Foster C, Pace M, Kaye S, Hopkins E, Jones M, Robinson N, et al.
AIDS
. 2017 Jun;
31(13):1847-1851.
PMID: 28609403
: The impact of antiretroviral therapy (ART) on the size of the HIV reservoir has implications for virological remission in adults, but is not well characterized in perinatally acquired infection....
10.
Tiraboschi J, Ray S, Patel K, Pace M, Phalora P, Robinson N, et al.
AIDS Res Hum Retroviruses
. 2016 Dec;
33(2):143-146.
PMID: 27917639
We show that intensification of treatment with maraviroc in patients chronically infected with HIV-1 receiving successful long-term antiretroviral therapy was not associated with improvements in HIV-related morbidity, HIV reservoir, microbial...